Section Arrow
Quote
BCAX.NASDAQ
- Bicara Therapeutics Inc.
Quotes are at least 15-min delayed:2026/06/01 16:10 EDT
After Hours
Last
 20.62
-- (--)
Bid
8.26
Ask
25.93
High 20.62 
Low 20.62 
Volume 15.43K 
Regular Hours (Closed)
Last
 20.57
-1.18 (-5.43%)
Day High 
21.73 
Prev. Close
21.75 
1-M High
23.8 
Volume 
740.35K 
Bid
8.26
Ask
25.93
Day Low
20.425 
Open
21.73 
1-M Low
18.62 
Market Cap 
1.43B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 20.96 
20-SMA 21.68 
50-SMA 21.41 
52-W High 24.25 
52-W Low 8.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.77/-2.56
Enterprise Value
1.43B
Balance Sheet
Book Value Per Share
7.82
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AIMAIM ImmunoTech Inc.0.8986+0.4908+120.35%-- 
After Hours 0.8518 -0.0468 -5.21%
GNTAGenenta Science SpA1.65+0.62+60.19%-- 
After Hours 1.61 -0.04 -2.42%
OTLKOutlook Therapeutics0.84635+0.11635+15.94%-- 
After Hours 0.843 -- --
RXRXRecursion Pharmaceuticals3.79+0.2+5.57%-- 
After Hours 3.7802 -- --
ADTXAditxt Inc.0.113-0.0042-3.58%-- 
After Hours 0.1414 +0.0284 +25.13%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.